Aug 17, 2018

Kelsey Moody — Antibody Mimetic for Parkinson’s Disease | LEAF

Posted by in categories: biotech/medical, life extension

Kelsey Moody, CEO of Ichor Therapeutics, discusses the creation of a gut-stable antibody mimetic for Parkinson’s disease and announces 10 million dollars in investment from Juvenescence into Ichor portfolio company Antoxerene Inc. at the Ending Age-Related Diseases conference in NYC.

More at:

Read more

Comments are closed.